MedPath

Comparison of Optical Coherence Tomographic Findings After Balloon Angioplasty With Two Different Paclitaxel-Coated Balloons for the Treatment of In-Stent Restenosis in Drug-Eluting Stents

Not Applicable
Terminated
Conditions
Coronary Artery Disease
Interventions
Device: balloon angioplasty with Pantera Lux
Device: balloon angioplasty with SeQuent Please
Registration Number
NCT02528474
Lead Sponsor
Yonsei University
Brief Summary

Drug-coated balloon technology (DCB) has recently attracted considerable interest as a promising alternative treatment option, particularly in the setting of in-stent restenosis (ISR). Optical coherence tomographic finding of restenosis lesions in drug-eluting stents (DESs) after Balloon Angioplasty with Two Different Paclitaxel-Coated Balloons will be compared between two paclitaxel-coated balloon devices; Pantera Lux™ and SeQuent® Please.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Patients ≥ 19 years old
  • Patients eligible for percutaneous coronary intervention
  • Single or more lesion(s) of restenosis requiring angioplasty in drug-eluting stent
  • Reference vessel diameter of target lesion ≥2.5 mm
Read More
Exclusion Criteria
  • Cardiogenic shock
  • Bifurcation lesion or totally occluded lesion
  • Unprotected left main trunk lesion
  • Allergies or hypersensitivities to antiplatelet, anticoagulation therapy, contrast media, or paclitaxel
  • Heavy calcified (definite calcified lesions on angiogram) or extremely tortuous lesions
  • Pregnant women or women with potential childbearing
  • Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator
  • Inability to understand or read the informed content
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pantera Luxballoon angioplasty with Pantera Lux-
SeQuent Pleaseballoon angioplasty with SeQuent Please-
Primary Outcome Measures
NameTimeMethod
Neointimal thickness & area9 months

measured by OCT analysis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath